Emerging treatment modalities for systemic therapy in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) has long been a major global clinical problem as one of the most common malignant tumours with a high rate of recurrence and mortality. Although potentially curative therapies are available for the early and intermediate stages, the treatment of patients with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Xin, Xu, Wenjing, Zong, Jingjing, Du, Xuanlong, Peng, Hao, Zhang, Yewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380325/
https://www.ncbi.nlm.nih.gov/pubmed/34419152
http://dx.doi.org/10.1186/s40364-021-00319-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380325/
https://www.ncbi.nlm.nih.gov/pubmed/34419152
http://dx.doi.org/10.1186/s40364-021-00319-3

Ejemplares similares